Search

Search Constraints

You searched for: Author/Creator Campbell, Daniel

Search Results

7. Ivacaftor treatment of cystic fibrosis in children aged 12 to <24 months and with a CFTR gating mutation (ARRIVAL): a phase 3 single-arm study. Issue 7 (July 2018)

9. Left ventricular systolic dysfunction is associated with poor functional outcomes after endovascular thrombectomy. (3rd September 2020)

10. Long-term safety and efficacy of tezacaftor–ivacaftor in individuals with cystic fibrosis aged 12 years or older who are homozygous or heterozygous for Phe508del CFTR (EXTEND): an open-label extension study. Issue 7 (July 2021)